Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase II Study of Zanzalintinib in Men With Aggressive Variant Prostate Cancer (NAPOLEON Study)

This is a multi-center single arm phase II study to evaluate the antitumor activity of zanzalintinib 60mg orally (PO) once daily in subjects with AVPC. Zanzali…

Aggressive Variant Prostate Carcinoma

Estimated

~$10 – $7,500

Deepak KilariNCT07218666